Cost
$110B+ in U.S. overall prenatal and neonatal care spending3, and growing 3% YoY3
20% of employer healthcare is for perinatal care annually
Pregnancy care needs innovation, Nuvo delivers.
Pregnancy care today is straining mothers, their families and their providers, while putting an enormous cost burden on payers.
Troubling Trends in Pregnancy Care Around Cost, Outcomes, and Access to Care.
Outcomes
52nd U.S. ranking in global infant mortality rates
32% increase in the number of women experiencing both pregnancy and childbirth complications
Easy to use
50% of U.S. counties do not have a practicing OB2
60% of (maternal) deaths could have been prevented if mothers had been able to more easily access quality prenatal and postpartum care
Nuvo can help address:
- Reduction in OB-ED visits - see more on this below
- Reduced admissions (prenatal and postpartum)
- Reduction in NICU admissions
- Reduced extended hospitalization
- Increased compliance with prenatal visits, particularly NST’s
- Reduction in NICU admissions
Learn about one customer’s experience with Nuvo
⅓
of all pregnancies spontaneously present to the OB-ED
$2.5B
is the annual cost to payers, resulting from the average OB-ED visit costs around $2000.
$600
In average out-of-pocket cost savings for members
Cut in OB-ED Visits via Remote Triage for Fetal Movement
Many OB-ED visits are due to decreased fetal movement or patients that haven’t felt their baby move for an extended period of time. Nuvo has demonstrated the ability to reduce OB-ED visits by enabling clinicians to remotely triage patients before making the trip to the OB-ED.
One Nuvo customer has reported that 100% of patients who experienced decreased fetal movement were able to avoid a potential trip to the OB-ED by undergoing NST triage from home instead.
Payers are reimbursing under existing CPT code 59025 for NST’s
“In the interest of expanding access to care and improving member outcomes, we are writing today to confirm that CPT Code 59025 is reimbursable with a place of service modifier (12) for at-home monitoring with remote monitoring solutions that are FDA cleared for on-label use for monitoring fetal heart rate (FHR), maternal heart rate (MHR), and Uterine Activity (UA).”